Castro, V M
Kong, S W
Clements, C C
Brady, R
Kaimal, A J
Doyle, A E
Robinson, E B
Churchill, S E
Kohane, I S
Perlis, R H
Article History
Received: 19 June 2015
Revised: 3 November 2015
Accepted: 5 November 2015
First Online: 5 January 2016
Competing interests
: Dr Perlis has received consulting fees or served on scientific advisory boards for Genomind, Healthrageous, Pamlab, Perfect Health, Pfizer, Proteus Biomedical, Psybrain and RID Ventures, and received patent fees/royalties from Concordant Rater Systems (now UBC/Medco). The remaining authors declare no conflict of interest.